Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A H Calvert

Showing results (31-40 of 148) with videos related to

Pageof 15
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1984
Inhibition of thymidylate synthetase by the new quinazoline antifolate, CB 3717; enzyme purification and kineticsA L Jackman, A H Calvert, L I Hart, et al.
Biochemical Pharmacology|October 15, 1984
Modulation of anti-metabolite effects. Effects of thymidine on the efficacy of the quinazoline-based thymidylate synthetase inhibitor, CB3717A L Jackman, G A Taylor, A H Calvert, et al.
Nature Medicine|August 1, 1996
Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancerI Sigalas, A H Calvert, J J Anderson, et al.
British Journal of Cancer|May 1, 1995
Molecular characterisation of two cell lines selected for resistance to the folate-based thymidylate synthase inhibitor, ZD1694S J Freemantle, A L Jackman, L R Kelland, et al.
Journal of Medicinal Chemistry|March 6, 1992
Syntheses and thymidylate synthase inhibitory activity of the poly-gamma-glutamyl conjugates of N-[5-[N-(3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino ]-2-thenoyl]-L-glutamic acid (ICI D1694) and other quinazoline antifolatesG M Bisset, K Pawelczak, A L Jackman, et al.
Advances in Experimental Medicine and Biology|January 1, 1989
Estimation of the in vitro and in vivo inhibitory effects of antifolates upon thymidylate synthase (TS) in whole cellsG A Taylor, A L Jackman, K Balmanno, et al.
Lancet (London, England)|March 12, 1983
JMS, successor to cisplatin in advanced ovarian carcinoma?E Wiltshaw, B D Evans, A C Jones, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
The pharmacokinetics of the quinazoline antifolate ICI D 1694 in mice and ratsD I Jodrell, D R Newell, W Gibson, et al.
Cancer Treatment Reports|November 1, 1983
Phase II study of JM8, a new platinum analog, in advanced ovarian carcinomaB D Evans, K S Raju, A H Calvert, et al.
Anti-Cancer Drug Design|March 1, 1989
Quinazoline antifolates inhibiting thymidylate synthase: computer modelling of the N10 substituentT R Jones, R F Betteridge, S Neidle, et al.
Pageof 15

Showing results (31-40 of 148) with videos related to

Sort By:
Pageof 15
Advances in Experimental Medicine and Biology|January 1, 1984
Inhibition of thymidylate synthetase by the new quinazoline antifolate, CB 3717; enzyme purification and kineticsA L Jackman, A H Calvert, L I Hart, et al.
Biochemical Pharmacology|October 15, 1984
Modulation of anti-metabolite effects. Effects of thymidine on the efficacy of the quinazoline-based thymidylate synthetase inhibitor, CB3717A L Jackman, G A Taylor, A H Calvert, et al.
Nature Medicine|August 1, 1996
Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancerI Sigalas, A H Calvert, J J Anderson, et al.
British Journal of Cancer|May 1, 1995
Molecular characterisation of two cell lines selected for resistance to the folate-based thymidylate synthase inhibitor, ZD1694S J Freemantle, A L Jackman, L R Kelland, et al.
Journal of Medicinal Chemistry|March 6, 1992
Syntheses and thymidylate synthase inhibitory activity of the poly-gamma-glutamyl conjugates of N-[5-[N-(3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino ]-2-thenoyl]-L-glutamic acid (ICI D1694) and other quinazoline antifolatesG M Bisset, K Pawelczak, A L Jackman, et al.
Advances in Experimental Medicine and Biology|January 1, 1989
Estimation of the in vitro and in vivo inhibitory effects of antifolates upon thymidylate synthase (TS) in whole cellsG A Taylor, A L Jackman, K Balmanno, et al.
Lancet (London, England)|March 12, 1983
JMS, successor to cisplatin in advanced ovarian carcinoma?E Wiltshaw, B D Evans, A C Jones, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
The pharmacokinetics of the quinazoline antifolate ICI D 1694 in mice and ratsD I Jodrell, D R Newell, W Gibson, et al.
Cancer Treatment Reports|November 1, 1983
Phase II study of JM8, a new platinum analog, in advanced ovarian carcinomaB D Evans, K S Raju, A H Calvert, et al.
Anti-Cancer Drug Design|March 1, 1989
Quinazoline antifolates inhibiting thymidylate synthase: computer modelling of the N10 substituentT R Jones, R F Betteridge, S Neidle, et al.
Pageof 15